The private equity group Permira has bid to acquire LivaNova, the US-listed medical devices manufacturer, two people familiar with the matter said.
The offer, made in mid-February, values the company’s shares at more than $80, the people said. That marks a premium to their $75 price on Wednesday, which gave the company a $3.7bn market value.
Talks are ongoing but there is no certainty that a deal will be reached, the people cautioned.
LivaNova produces medical equipment such as life-support machines, heart valves and oxygenators and has nearly 4,000 staff, according to its website. It is based in London but listed on the Nasdaq stock exchange. It delisted from the London Stock Exchange in 2017.
Source: The Financial Times
By Kaye Wiggins and Bryce Elder
